PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release
NDC 69097-531, pantoprazole sodium granules, suspension, from Cipla USA Inc..
- Product NDC
- 69097-531
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217458
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-531 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PANTOPRAZOLE SODIUM40 mg/1
Pharmacologic classes
Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-531-53 | 69097053153 | 30 PACKET in 1 CARTON (69097-531-53) / 1 SUSPENSION in 1 PACKET (69097-531-31) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/195e06db-b76c-4470-b6a5-a3979c25046dNADAC price for package 69097053153
GET /v1/drugs/nadac/69097053153
Use it
Look up 69097-531 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-531 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-531. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.